TUESDAY, June 25, 2024 (HealthDay News) — For decades, millions of Americans popped a low-dose aspirin each day to lower their heart risks. Then, accumulated data prompted the nation’s two leading cardiology groups — the American College of Cardiology and the American Heart Association — to overturn advisories in 2019Continue Reading

TUESDAY, June 25, 2024 (HealthDay News) — A well-established cholesterol-lowering drug appears to significantly slow the progression of a diabetes-related eye disease, a new trial shows. Fenofibrate (Tricor) has been approved since 2004 as a means of lowering cholesterol. Now, this new study shows that fenofibrate also can reduce theContinue Reading